Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP263444.RAAwffOAN231JjahfrUqTTutuOPpWw4sJ0TkNU9ynUQ_E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP263444.RAAwffOAN231JjahfrUqTTutuOPpWw4sJ0TkNU9ynUQ_E130_assertion type Assertion NP263444.RAAwffOAN231JjahfrUqTTutuOPpWw4sJ0TkNU9ynUQ_E130_head.
- NP263444.RAAwffOAN231JjahfrUqTTutuOPpWw4sJ0TkNU9ynUQ_E130_assertion description "[The authors measured TPMT activity as well as erythrocyte levels of 6TGN (E-6TGN) and methylated 6MP metabolites (E-MeMP) during 6MP therapy in 439 children with acute lymphoblastic leukemia, 5 of whom later developed secondary myelodysplasia or acute myeloid leukemia (sMDS/AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP263444.RAAwffOAN231JjahfrUqTTutuOPpWw4sJ0TkNU9ynUQ_E130_provenance.
- NP263444.RAAwffOAN231JjahfrUqTTutuOPpWw4sJ0TkNU9ynUQ_E130_assertion evidence source_evidence_literature NP263444.RAAwffOAN231JjahfrUqTTutuOPpWw4sJ0TkNU9ynUQ_E130_provenance.
- NP263444.RAAwffOAN231JjahfrUqTTutuOPpWw4sJ0TkNU9ynUQ_E130_assertion SIO_000772 10491537 NP263444.RAAwffOAN231JjahfrUqTTutuOPpWw4sJ0TkNU9ynUQ_E130_provenance.
- NP263444.RAAwffOAN231JjahfrUqTTutuOPpWw4sJ0TkNU9ynUQ_E130_assertion wasDerivedFrom befree-2016 NP263444.RAAwffOAN231JjahfrUqTTutuOPpWw4sJ0TkNU9ynUQ_E130_provenance.
- NP263444.RAAwffOAN231JjahfrUqTTutuOPpWw4sJ0TkNU9ynUQ_E130_assertion wasGeneratedBy ECO_0000203 NP263444.RAAwffOAN231JjahfrUqTTutuOPpWw4sJ0TkNU9ynUQ_E130_provenance.